Table 5.

Enrollment table for Active Phase 1-3 drug trials

	# of trials	Target enrollment	Average/trial	median	min	max
Phase 1	47	1,591	34	20	3	120
Phase 2	72	9,091	126	67	10	732
Phase 3	20	6,005	300	310	50	600
Total	139	16,687